US2020054803A1PendingUtilityA1

Anti-Extravasation Catheter

Assignee: CANNUFLOW INCPriority: Oct 24, 2006Filed: Oct 28, 2019Published: Feb 20, 2020
Est. expiryOct 24, 2026(~0.3 yrs left)· nominal 20-yr term from priority
A61M 2025/0036A61M 25/0029A61M 25/007A61M 2025/0004A61B 5/053A61M 25/0026A61B 5/01A61B 5/02152A61B 5/14539A61M 2025/0039A61M 5/5086A61M 5/14A61M 1/0084A61M 1/0058A61B 5/0084A61M 1/77
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosed devices and methods provide for the minimization of fluid extravasation during use of infusion catheters such as peripherally inserted central catheters and central venous catheters. The anti-extravasation catheter allows a surgeon to drain fluids from soft tissue surrounding an infusion site while also providing fluid inflow to a patient.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . An anti-extravasation system comprising:
 a catheter having a length and an outer diameter suitable for extending from a peripheral vein insertion point on a patient to a treatment site, said catheter characterized by an elongated venous section located distal to an interstitial section and comprising:
 an inflow lumen; 
 at least one drainage lumen; and 
 a plurality of apertures disposed in the interstitial section of the catheter, said apertures in fluid communication with the drainage lumen and adapted to drain fluid from tissue surrounding the insertion point when the catheter is operably disposed within the patient; 
 wherein the venous section of the catheter comprises an outer surface and is structured to prevent fluid communication between the outer surface of the venous section and the drainage lumen; and 
   a hub proximal to the interstitial section and placed in fluid communication with the inflow lumen and the drainage lumen.

Join the waitlist — get patent alerts

Track US2020054803A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.